Canada markets open in 8 hours 22 minutes

LLY Jun 2023 200.000 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.57000.0000 (0.00%)
As of 03:11PM EST. Market open.
Full screen
Previous Close0.5700
Open0.5700
Bid0.0000
Ask0.0000
Strike200.00
Expire Date2023-06-16
Day's Range0.5700 - 0.5700
Contract RangeN/A
Volume1
Open InterestN/A
  • Reuters

    Drug companies face COVID cliff in 2023 as sales set to plummet

    Pharmaceutical companies that made billions from the pandemic over the past two years selling vaccines and treatments are now up against a steep COVID cliff and investor pressure to spend their windfalls wisely. Western drugmakers including Pfizer Inc, BioNTech SE, Moderna Inc, Gilead Sciences Inc, AstraZeneca Plc and Merck & Co are estimated to have brought in about $100 billion in revenue from COVID vaccines and treatments in 2022. Company and analyst estimates suggest those sales could fall by nearly two-thirds this year due to built up product inventories around the world including in the countries that pay the most.

  • Reuters

    FOCUS-Drug companies face COVID cliff in 2023 as sales set to plummet

    Pharmaceutical companies that made billions from the pandemic over the past two years selling vaccines and treatments are now up against a steep COVID cliff and investor pressure to spend their windfalls wisely. Western drugmakers including Pfizer Inc, BioNTech SE , Moderna Inc, Gilead Sciences Inc, AstraZeneca Plc and Merck & Co are estimated to have brought in about $100 billion in revenue from COVID vaccines and treatments in 2022. Company and analyst estimates suggest those sales could fall by nearly two-thirds this year due to built up product inventories around the world including in the countries that pay the most.

  • Zacks

    AbbVie Q4 Preview: What's in Store?

    AbbVie has put in a mixed earnings performance, exceeding bottom line estimates in five consecutive quarters but falling short of sales expectations in each instance.